WORLDWIDE, 26,000 PEOPLE DIE FROM CANCER EACH DAY

By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million. 

Earlier diagnosis of cancer results in significantly higher survival rates compared to late-stage diagnosis, increasing the availability of treatment options and improving chances of recovery and a better quality of life.
cancer_MG_2484.jpg
Chroma-Background.jpg

DXCOVER BRAIN CANCER

With the Dxcover Brain Cancer Liquid Biopsy, doctors will finally have a fast, inexpensive and easy way to accurately test for brain cancer

90%

OF PATIENTS SURVIVE WHEN CANCER IS FOUND EARLY. EARLY DIAGNOSIS BEATS CANCER. 

Reference - CRUK Statistics impact of early diagnosis

THE DXCOVER LIQUID BIOPSY IS A BLOOD TEST FOR EARLY DETECTION OF CANCER.

The Dxcover Platform and patented Drop Dry Detect method enables rapid development of a range of tests.

Our Dxcover Cancer project is developing  liquid biopsies for the most  common cancers.

Our Dxcover Brain Cancer liquid biopsy has successfully completed two  clinical studies.